Dana-Farber Cancer Institute: Study finds that patients with cancer and a suppressed immune system are at high risk for severe COVID if treated with systemic drug therapies

Press/Media

Period	3 Nov 2022

Media coverage

Title	Dana-Farber Cancer Institute: Study finds that patients with cancer and a suppressed immune system are at high risk for severe COVID if treated with systemic drug therapies
Media name/outlet	India Pharma News
Country/Territory	India
Date	3/11/22
URL	metabase.moreover.com/noarticleurl?type=psh&lni=66SN-8151-JB5M-W3YP-00000-00
Persons	Gary Schwartz, Michael Wotman